Proteomics International Laboratories |
High $0.88 |
Low $0.86 |
Trades 19 |
Turnover $55,369 |
Volume 64,140 |
| 30 June 2023 at 3:08pm | ||||
|
Market Cap (13-Nov) $16,206,565 (840th) |
Close (30-Jun) $0.86 |
Volume (30-Jun) 64,140 |
Shortsold (6-Nov) 92,277 (0.06%) (494th) |
|
52w High $0.86 |
52w Low $0.090 |
P/E - |
EPS -0.05 |
European PromarkerD patents expanded beyond diabetes
PIQ released this announcement to the ASX on 25 July 2022, 8:13. The announcement is marked as price sensitive, and is 2 page(s) in length and 156.32kb in size.
You can view all announcements from PIQ and see how they appear on a price chart on the announcements page.
At the date of this announcement, PIQ was 0.000% short sold according to ASIC data. It was ranked the 654th most shorted stock on the ASX. It is now ranked as the 494th most shorted stock on the ASX with 0.056% of total shares short sold as of the latest reported data (06 November 2026).
| Other Recent Announcements from PIQ | |
|---|---|
| Sonic Healthcare USA signs licence for PromarkerD in the US | 10 May 2023, 11:41 |
| Trading Halt | 8 May 2023, 9:15 |
| World Endometriosis Congress - New diagnostic test showcased | 5 May 2023, 8:15 |
| European PromarkerD patents expanded beyond diabetes | 25 July 2022, 8:13 |
| Investor Presentation | 18 July 2022, 11:06 |
| Exercise of Performance Rights | 11 July 2022, 10:59 |
| Application for quotation of securities - PIQ | 11 July 2022, 10:58 |
If you were already registered, log in here.